177 related articles for article (PubMed ID: 9114142)
1. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate.
Martinez S; Gonzalez M; Vernaza ME
Clin Infect Dis; 1997 Feb; 24(2):165-9. PubMed ID: 9114142
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis.
Llanos-Cuentas A; EchevarrÃa J; Cruz M; La Rosa A; Campos P; Campos M; Franke E; Berman J; Modabber F; Marr J
Clin Infect Dis; 1997 Sep; 25(3):677-84. PubMed ID: 9314461
[TBL] [Abstract][Full Text] [Related]
4. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
6. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
Ramesh V; Kumar J; Kumar D; Salotra P
Indian J Dermatol Venereol Leprol; 2010; 76(2):138-44. PubMed ID: 20228542
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
Tallab TM; Bahamdam KA; Mirdad S; Johargi H; Mourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Jamal A
Int J Dermatol; 1996 Aug; 35(8):594-7. PubMed ID: 8854166
[TBL] [Abstract][Full Text] [Related]
9. Fractional Ablative CO2 Laser Followed by Topical Application of Sodium Stibogluconate for Treatment of Active Cutaneous Leishmaniasis: A Randomized Controlled Trial.
Artzi O; Sprecher E; Koren A; Mehrabi JN; Katz O; Hilerowich Y
Acta Derm Venereol; 2019 Jan; 99(1):53-57. PubMed ID: 30281141
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
Ranawaka RR; Weerakoon HS
J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of ocular leishmaniasis.
Abrishami M; Soheilian M; Farahi A; Dowlati Y
Eur J Dermatol; 2002; 12(1):88-9. PubMed ID: 11809607
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Ranawaka RR; Weerakoon HS; de Silva SH
Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study.
Negi AK; Sharma NL; Mahajan VK; Ranjan N; Kanga AK
Indian J Dermatol Venereol Leprol; 2007; 73(4):280. PubMed ID: 17682296
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
Almeida R; D'Oliveira A; Machado P; Bacellar O; Ko AI; de Jesus AR; Mobashery N; Brito Santos J; Carvalho EM
J Infect Dis; 1999 Nov; 180(5):1735-7. PubMed ID: 10515844
[TBL] [Abstract][Full Text] [Related]
17. Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort.
Renert-Yuval Y; Enk CD; Murad S; Yofe V; Gozal D; Molho-Pessach V
J Am Acad Dermatol; 2019 Oct; 81(4):1013-1015. PubMed ID: 30731176
[No Abstract] [Full Text] [Related]
18. Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis.
Hilerowicz Y; Koren A; Mashiah J; Katz O; Sprecher E; Artzi O
Pediatr Dermatol; 2018 May; 35(3):366-369. PubMed ID: 29574997
[TBL] [Abstract][Full Text] [Related]
19. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
